Day: October 3, 2024

Feedback clients

Eclevar MedTech and RegenLab entered into an agreement to conduct all upcoming PMCF studies for chronic diabetic foot ulcer devices

Paris, October 03, 2024 – Eclevar MedTech, a leading european contract research organization (CRO) specializing in medical devices, proudly announces its colleboration with by RegenLab

3 October 2024

Access the Eclevar Knowledge Center

Why validated Patient Reported Outcomes (PROs) should be used in your PMCF surveys?

Why the PMCF is so crucial under EU MDR?

Insights for the Robust Clinical Evaluation Report (CER) for EU MDR

WEBINAR April 2th, 2025 – Data Matters: Ensuring Quality for Clinical Trial Success

15-Minute Free Consulting

Got a question, an idea, or a project in mind? Get 15 minutes with one of our experts—no strings attached. Just a quick, constructive chat to help you move forward with confidence.

Legal notices

VISIT US

ECLEVAR FRANCE:
231 rue Saint-Honoré, 75001 Paris, France

ECLEVAR GMBH
ERFURT, Erfurt Hauptbahnhof
4th, 5th floor
Bahnhofstr. 38 Erfurt 99084

ECLEVAR Australia
Umina Beach NSW 2257, Australia

ECLEVAR UK Limited
3rd Floor 207 Regent Street, London, W1B 3HH

OUR SERVICES